Clinical Trials in New York

Showing 3421-3440 of 22,668 trials

Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and PPIX Concentrations in Participants With EPP

NCT05308472

This is a Phase 2, multi-center, double-blind, placebo-controlled, parallel group study of bitopertin to evaluate the safety, tolerability, efficacy, and PPIX concentration change in participants with EPP. Participants may roll over to an open label extension portion after completing the double-blind treatment period.

Erythropoietic Protoporphyria

Disc Medicine, Inc75 participantsStarted Oct 2022

Birmingham, Alabama, United States • San Francisco, California, United States • Miami, Florida, United States +6 more locations

RECRUITINGPhase 1< 1 mile

Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL

NCT04872478

This is a Phase I, open-label, non-randomized, dose escalation study in adolescents and adults with relapsed/refractory acute myeloid leukemia, acute lymphoblastic leukemia, or mixed phenotype acute leukemia. Patients will receive continuous oral MRX-2843 in 28 day cycles at predefined dose cohorts.

Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMixed Phenotype Acute Leukemia

Meryx, Inc.50 participantsStarted Apr 2022

Atlanta, Georgia, United States • Atlanta, Georgia, United States • New York, New York, United States

Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and PPIX Concentrations in Participants With EPP

Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL

Find Trials by Condition in New York

A Randomized Clinical Trial Assessing Smoking Cessation Interventions In Dental Clinic Smokers

Investigating Mechanisms to Explain Age Associated Differences in Quality of Life Among Breast Cancer Patients

PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56

DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes

Amyotrophic Lateral Sclerosis (ALS) Families Project

Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS)

The CONQUER Trial - Cessation Of Nicotine, QUitting With E-cigarette Reduction

Proton and Photon Consortium Registry (PPCR): A Multi Center Registry of Pediatric Patients Treated With Radiation Therapy

Use of the Impella BTR™ in Patients With Heart Failure: An Early Feasibility Study

Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors

Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer

Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Effect of Support for Low-Income Mothers of Preterm Infants

[18F]PI-2620 Phase 3 Histopathological Study

Allied Cleft & Craniofacial Quality-Improvement and Research Network (ACCQUIREnet)

Evaluation of COVID-19 and Flu A/B 3 in 1 Combo Rapid Test

A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE)

A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase Inhibitors